Title | Description |
|---|---|
| Trial ID | KF7013-02 |
| Compound | Neridronic Acid |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | Efficacy and safety of intravenous neridronic acid in CRPS |
| Indication | Complex Regional Pain Syndrome , CRPS |
| UTN | U1111-1187-8036 |
| CTG ID | NCT03530345 |
| CTIS ID (former EudraCT) | 2016-003833-91 |
| Trial status | Terminated |
| FPI | May 30, 2018 |
| LPO | July 31, 2019 |
| Countries | Germany, United States |
| Gender | All |
| Age | 18 and 80 years |
| Results | Yes |
| Pubmed | |
| Documents | media-statement-discontunuation-of-neridronate-trials kf7013-02-expert-statement kf7013-02-lay-summary-english kf7013-02-lay-summary-english-for-australia kf7013-02-lay-summary-english-for-new-zealand kf7013-02-lay-summary-french kf7013-02-lay-summary-german kf7013-02-lay-summary-korean kf7013-02-lay-summary-spanish |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.